Canlyniadau Chwilio - David J. Inwards
- Dangos 1 - 20 canlyniadau o 76
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
-
4
-
5
-
6
Early lymphocyte recovery post‐autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease gan Luis F. Porrata, David J. Inwards, Ivana N. Micallef, Stephen M. Ansell, Susan M. Geyer, Svetomir N. Markovic
Cyhoeddwyd 2002Artigo -
7
-
8
-
9
-
10
-
11
-
12
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders gan Andrew P. Sciallis, Mark E. Law, David J. Inwards, Rebecca F. McClure, William R. Macon, Paul J. Kurtin, Ahmet Doǧan, Andrew L. Feldman
Cyhoeddwyd 2012Artigo -
13
Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults gan Arianna Rodriguez, Keith J. Horvath, Nadia Dowshen, Raina V. Voss, Jonathan Warus, Megan A Jacobs, Kacie M. Kidd, David J. Inwards-Breland, Jill Blumenthal
Cyhoeddwyd 2024Artigo -
14
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study gan Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Dennis A. Gastineau, Mark R. Litzow, Jeffrey L. Winters, Svetomir N. Markovic
Cyhoeddwyd 2008Artigo -
15
Testicular lymphoma is associated with a high incidence of extranodal recurrence gan Rafaël Fonseca, Thomas M. Habermann, Joseph P. Colgan, Brian Patrick O’Neill, William L. White, Thomas E. Witzig, Kathleen S. Egan, James A. Martenson, Lawrence J. Burgart, David J. Inwards
Cyhoeddwyd 2000Artigo -
16
Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatme... gan David J. Inwards, Paul A. S. Fishkin, David W. Hillman, David W. Brown, Stephen M. Ansell, Paul J. Kurtin, Rafaël Fonseca, Roscoe F. Morton, Michael H. Veeder, Thomas E. Witzig
Cyhoeddwyd 2008Artigo -
17
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate gan MA Gertz, Martha Q. Lacy, Angela Dispenzieri, Stephen M. Ansell, M. A. Elliott, D A Gastineau, David J. Inwards, Ivana N. Micallef, Luis F. Porrata, Ayalew Tefferi, Mark R. Litzow
Cyhoeddwyd 2004Artigo -
18
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial gan Patrick B. Johnston, Betsy LaPlant, Ellen D. McPhail, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Joseph P. Colgan, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas E. Witzig
Cyhoeddwyd 2016Artigo -
19
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma gan Carrie A. Thompson, Kathleen J. Yost, Matthew J. Maurer, Cristine Allmer, Umar Farooq, Thomas M. Habermann, David J. Inwards, William R. Macon, Brian K. Link, Allison Rosenthal, James R. Cerhan
Cyhoeddwyd 2018Artigo -
20
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study gan Stephen M. Ansell, Hui Tang, Paul J. Kurtin, Patricia Koenig, David J. Inwards, Keith Shah, Steven C. Ziesmer, Andrew L. Feldman, Radha M. Rao, Mamta Gupta, Charles Erlichman, Thomas E. Witzig
Cyhoeddwyd 2011Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Lymphoma
Oncology
Gastroenterology
Transplantation
Surgery
Immunology
Chemotherapy
Biology
Hematopoietic stem cell transplantation
Rituximab
Confidence interval
Genetics
Diffuse large B-cell lymphoma
Physics
Stem cell
Antibody
Cancer
Follicular lymphoma
Autologous stem-cell transplantation
Hazard ratio
Multiple myeloma
Psychology
Cohort
Environmental health
Haematopoiesis
Lymphocyte
Mantle cell lymphoma
Progression-free survival